Stay updated on Sepofarsen Repeat-dose in LCA10 Clinical Trial

Sign up to get notified when there's something new on the Sepofarsen Repeat-dose in LCA10 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sepofarsen Repeat-dose in LCA10 Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The new screenshot appears to reflect minor formatting updates to the Study Details page without altering core trial information such as the NCT number, conditions, locations, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-30T13:33:00.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing study sites in Iowa, Minas Gerais, São Paulo, Ontario, and Quebec. Removed the older individual location entries for those regions and the HHS Vulnerability Disclosure link.
    Difference
    0.6%
    Check dated 2025-12-23T09:22:25.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    No significant changes detected between the two screenshots. The page content and structure appear unchanged, including the study overview, eligibility criteria, and locations.
    Difference
    0.1%
    Check dated 2025-12-16T03:02:06.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.1 to v3.3.2 on the page.
    Difference
    0.0%
    Check dated 2025-12-01T17:41:14.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1. This indicates a minor page update without affecting study content.
    Difference
    0.0%
    Check dated 2025-11-24T14:36:42.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Removed the banner about government funding and NIH operating status from the page. The study details and page structure remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:55:12.000Z thumbnail image

Stay in the know with updates to Sepofarsen Repeat-dose in LCA10 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sepofarsen Repeat-dose in LCA10 Clinical Trial page.